← Leaderboards
Harry L Malech
Niaid Extramural Activities
$11,932
Attributed
$11,932
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$11,932 · 1
By mechanism
U54$11,932 · 1
Top collaborators
No co-investigators on record.
Most similar at Niaid Extramural Activities
Same institution · by research overlap
Others in their field
Other Emerging Leaders on “Gene Therapy”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$26,358,801
- George Mitra · Leidos Biomedical Research, Inc.$23,876,869
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
Research focus
Gene TherapyImmuneNeutrophilChronic Granulomatous DiseaseHematopoietic Stem CellsClinical TrialsCellsCd34 GeneLinkInfectionMarrowDefectMutationDesignAffectInheritedAutologousGenesBloodBasic ScienceTransplantationGene CorrectionStem CellsAllogenic
Grant awards (54)
Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies$1,096,673
ZIA · FY2025 · AI · contact PI
Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies$796,377
ZIA · FY2024 · AI · contact PI
Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies$976,015
ZIA · FY2023 · AI · contact PI
Zotatifin treatment of adults with mild to moderate COVID-19$35,616
ZIA · FY2023 · AI · contact PI
Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies$931,259
ZIA · FY2022 · AI · contact PI
Zotatifin treatment of adults with mild to moderate COVID-19$16,385
ZIA · FY2022 · AI · contact PI
Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies$1,242,170
ZIA · FY2021 · AI · contact PI
Zotatifin treatment of adults with mild to moderate COVID-19$87,364
ZIA · FY2021 · AI · contact PI
Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies$669,910
ZIA · FY2020 · AI · contact PI
Gene Therapy Basic Research to Treat Inherited Primary Immune Deficiencies$796,028
ZIA · FY2019 · AI · contact PI
Basic Research on Hematopoietic Human Stem Cells$759,845
ZIA · FY2019 · AI · contact PI
Gene Therapy Basic Research to Treat Inherited Primary Immune Deficiencies$830,307
ZIA · FY2018 · AI · contact PI
Basic Research on Hematopoietic Human Stem Cells$792,565
ZIA · FY2018 · AI · contact PI
Analysis of Patients Reated for Chronic Granulomatous Disease Since January 1, 1995$11,932
U54 · FY2018 · AI · contact PI
Basic Research on Hematopoietic Human Stem Cells$719,889
ZIA · FY2017 · AI · contact PI
Gene Therapy Basic Research to Treat Inherited Primary Immune Deficiencies$703,148
ZIA · FY2017 · AI · contact PI
Basic Research on Hematopoietic Human Stem Cells$758,785
ZIA · FY2016 · AI · contact PI
Gene Therapy Basic Research to Treat Inherited Primary Immune Deficiencies$758,785
ZIA · FY2016 · AI · contact PI
Basic Research on Hematopoietic Human Stem Cells$465,906
ZIA · FY2015 · AI · contact PI
Gene Therapy Basic Research to Treat Inherited Primary Immune Deficiencies$465,906
ZIA · FY2015 · AI · contact PI
Basic Research on Hematopoietic Human Stem Cells$593,980
ZIA · FY2014 · AI · contact PI
Gene Therapy Basic Research to Treat Inherited Primary Immune Deficiencies$593,980
ZIA · FY2014 · AI · contact PI
Basic Research on Hematopoietic Human Stem Cells$494,034
ZIA · FY2013 · AI · contact PI
Gene Therapy Basic Research to Treat Inherited Primary Immune Deficiencies$494,034
ZIA · FY2013 · AI · contact PI
Basic Research on Hematopoietic Human Stem Cells$425,190
ZIA · FY2012 · AI · contact PI
Gene Therapy Basic Research to Treat Inherited Primary Immune Deficiencies$418,055
ZIA · FY2012 · AI · contact PI
Basic Research on Hematopoietic Human Stem Cells$479,513
ZIA · FY2011 · AI · contact PI
Gene Therapy Basic Research to Treat Inherited Primary Immune Deficiencies$435,010
ZIA · FY2011 · AI · contact PI
Basic Research on Hematopoietic Human Stem Cells$528,467
ZIA · FY2010 · AI · contact PI
Gene Therapy Basic Research to Treat Inherited Primary Immune Deficiencies$442,270
ZIA · FY2010 · AI · contact PI
Basic Research on Hematopoietic Human Stem Cells$525,632
ZIA · FY2009 · AI · contact PI
Gene Therapy Basic Research to Treat Inherited Primary Immune Deficiencies$447,990
ZIA · FY2009 · AI · contact PI
Gene Therapy Basic Research to Treat Inherited Immune Deficiencies$387,461
Z01 · FY2008 · AI · contact PI
Basic Research on Hematopoietic Adult Human Stem Cells$326,019
Z01 · FY2008 · AI · contact PI
Clinical Treatment of Patients with Chronic Graft Versus Host Disease$100,715
Z01 · FY2008 · AI · contact PI
Gene Therapy Basic Research to Treat Inherited Immune Deficiencies$3,892,323
Z01 · FY2007 · AI · contact PI
Clinical Diagnostic Studies and Treatment of Patients with Immune Deficiencies$485,200
Z01 · FY2007 · AI · contact PI
Basic Research on Hematopoietic Adult Human Stem Cells$343,210
Z01 · FY2007 · AI · contact PI
Gene Therapy Clinical Trials for X-linked Severe Combined Immunodeficiency$194,616
Z01 · FY2007 · AI · contact PI
Clinical Treatment of Patients with Chronic Graft Versus Host Disease$105,856
Z01 · FY2007 · AI · contact PI
Gene Therapy and Allogeneic Transplantation For Immune D$0
Z01 · FY2006 · AI · contact PI
Biology Of Peripheral Blood Progenitors--a Target For Ge$0
Z01 · FY2006 · AI · contact PI
Gene Therapy For Immune Deficiencies$0
Z01 · FY2005 · AI
Biology Of Peripheral Blood Progenitors$0
Z01 · FY2005 · AI
Gene Therapy For Immune Deficiencies$0
Z01 · FY2004 · AI
Peripheral Blood Progenitors--Target For Gene Transfer$0
Z01 · FY2004 · AI
Gene Therapy For Immune Deficiencies$0
Z01 · FY2003 · AI
Biology of Peripheral Blood Progenitors in Gene Transfer$0
Z01 · FY2003 · AI
Gene Therapy For Immune Deficiencies$0
Z01 · FY2002 · AI
Biology Of Peripheral Blood Progenitors--a Target For Ge$0
Z01 · FY2002 · AI
Gene Therapy For Immune Deficiencies$0
Z01 · FY2001 · AI
Peripheral Blood Progenitors--a Target For Gene Transfer$0
Z01 · FY2001 · AI
GENE THERAPY FOR IMMUNE DEFICIENCIES$0
Z01 · FY2000 · AI
BIOLOGY OF PERIPHERAL BLOOD PROGENITORS--A TARGET FOR GENE TRANSFER$0
Z01 · FY2000 · AI